Litigation Details for MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC. (S.D. Fla. 2020)
✉ Email this page to a colleague
MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC. (S.D. Fla. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-01-15 |
Court | District Court, S.D. Florida | Date Terminated | 2020-01-29 |
Cause | 15:0002 Antitrust Litigation | Assigned To | Robert Nichols Scola Jr. |
Jury Demand | Plaintiff | Referred To | Edwin G. Torres |
Parties | GILEAD HOLDINGS, LLC | ||
Patents | 6,043,230; 6,642,245; 6,703,396; 7,390,791; 7,803,788; 8,754,065; 9,296,769 | ||
Attorneys | Jorge Alejandro Mestre | ||
Firms | White & Case, LLP* | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC.
Biologic Drugs cited in MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC.
Details for MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC. (S.D. Fla. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-01-14 | 1 | 5,977,089; and 6,043,230 (the “TDF Patents”). Teva asserted that the TDF patents were invalid, unenforceable…listed patent(s) and/or the patent is invalid and unenforceable. Simply by listing the patents in the…ANDA applicant for patent infringement. If the brand manufacturer brings a patent infringement action…legitimate patent protection or ferret out invalid, unenforceable, or narrow drug patents. 4. …has applied for patents that claim the formulation of TAF with FTC. See, e.g., U.S. Patent Application | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |